CHAMPION-1: A phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma.
Times cited: 17
Monoclonal gammopathy of undetermined significance: A consensus statement: Guideline.
British Journal of Haematology.
Times cited: 66
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer.
Journal of Clinical Oncology.
Times cited: 356